The safety of St John's wort (Hypericum perforatum) in pregnancy and lactation: A systematic review of rodent studies
- PMID: 29708295
- DOI: 10.1002/ptr.6099
The safety of St John's wort (Hypericum perforatum) in pregnancy and lactation: A systematic review of rodent studies
Abstract
Herbal products are popular among women during the perinatal period. St John's wort (SJW), Hypericum perforatum, is a common remedy for mild depression, a problem prevalent in this population. Although the safety of herbal products must be investigated, ethical issues constrain intervention studies in humans. Hence, animal studies often inform clinical decisions. The objective of this study is to systematically review rodent studies assessing the safety of SJW during the perinatal period. A literature search to November 10, 2017, identified 10 rodent studies that met a priori inclusion criteria. Study quality was evaluated according to both the Systematic Review Centre for Laboratory animal Experimentation tool for assessing bias and recommendations for appropriate reporting of herbal medicine research. Significant methodological limitations were found in each of the studies reviewed. These limitations include the lack of botanical verification and omission of extract characterization, inadequate explanation of dosage rationale, and absence of bias limiting protocols. Critical appraisal with contemporary tools indicates that each of the reviewed studies lacks appropriate rigour, rendering the results unreliable. Despite this, these papers are used in the rationale for recommending or contraindicating SJW during pregnancy and lactation.
Keywords: Hypericum perforatum; St John's wort; animal studies; perinatal depression; pregnancy; safety.
Copyright © 2018 John Wiley & Sons, Ltd.
Similar articles
-
St John's wort for depression.Cochrane Database Syst Rev. 2000;(2):CD000448. doi: 10.1002/14651858.CD000448. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000448. doi: 10.1002/14651858.CD000448.pub2. PMID: 10796719 Updated.
-
St John's wort for depression.Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000448. doi: 10.1002/14651858.CD000448.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2008 Oct 08;(4):CD000448. doi: 10.1002/14651858.CD000448.pub3. PMID: 15846605 Updated.
-
Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.J Altern Complement Med. 2009 Aug;15(8):827-36. doi: 10.1089/acm.2009.0066. J Altern Complement Med. 2009. PMID: 19614563
-
A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.Int Clin Psychopharmacol. 2001 Sep;16(5):239-52. doi: 10.1097/00004850-200109000-00001. Int Clin Psychopharmacol. 2001. PMID: 11552767
-
An update on clinical drug interactions with the herbal antidepressant St. John's wort.Curr Drug Metab. 2008 Jun;9(5):394-409. doi: 10.2174/138920008784746391. Curr Drug Metab. 2008. PMID: 18537576
Cited by
-
Combined fractional anisotropy and subcortical volumetric deficits in patients with mild-to-moderate depression: Evidence from the treatment of antidepressant traditional Chinese medicine.Front Neurosci. 2022 Aug 23;16:959960. doi: 10.3389/fnins.2022.959960. eCollection 2022. Front Neurosci. 2022. PMID: 36081664 Free PMC article.
-
St. John's Wort usage in treating of perinatal depression.Front Behav Neurosci. 2023 Jan 5;16:1066459. doi: 10.3389/fnbeh.2022.1066459. eCollection 2022. Front Behav Neurosci. 2023. PMID: 36688122 Free PMC article. No abstract available.
-
Meta-analysis of Shugan Jieyu Capsule for depression in patients with coronary heart disease.Medicine (Baltimore). 2023 Aug 25;102(34):e34685. doi: 10.1097/MD.0000000000034685. Medicine (Baltimore). 2023. PMID: 37653746 Free PMC article.
-
Improved Resting-State Functional Dynamics in Post-stroke Depressive Patients After Shugan Jieyu Capsule Treatment.Front Neurosci. 2020 Apr 16;14:297. doi: 10.3389/fnins.2020.00297. eCollection 2020. Front Neurosci. 2020. PMID: 32372901 Free PMC article.
-
Advanced in Vitro Safety Assessment of Herbal Medicines for the Treatment of Non-Psychotic Mental Disorders in Pregnancy.Front Pharmacol. 2022 Jun 23;13:882997. doi: 10.3389/fphar.2022.882997. eCollection 2022. Front Pharmacol. 2022. PMID: 35814220 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous